In vitro anti-aggregatory effects of the GP IIb/IIIa antagonist eptifibatide on feline platelets.
Bright
Janice M
JM
Dowers
Kristy
K
Hellyer
Peter
P
D000818:Animals; D001791:Blood Platelet Disorders / Q000188:drug therapy* / Q000662:veterinary; D001792:Blood Platelets / Q000187:drug effects* / Q000502:physiology; D002415:Cats; D002986:Clinical Trials as Topic; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000662:veterinary*; D004305:Dose-Response Relationship, Drug; D000077542:Eptifibatide; D006323:Heart Arrest / Q000209:etiology / Q000662:veterinary*; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D010455:Peptides / Q000009:adverse effects* / Q000494:pharmacology*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000494:pharmacology*
D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D000077542:Eptifibatide